Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Mirum Pharmaceuticals, Inc. (MIRM) had Current Assets of $569.44M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$159.88M |
|
$-790.15M |
|
$28.80M |
|
$131.08M |
|
$949.35M |
|
$-789.47M |
|
$-0.21M |
|
$-789.68M |
|
$-789.68M |
|
$-790.15M |
|
$-790.15M |
|
$-790.15M |
|
$-790.15M |
|
$-789.47M |
|
$-782.14M |
|
58.85M |
|
58.85M |
|
$-13.43 |
|
$-13.43 |
|
| Balance Sheet Financials | |
|
Current Assets |
$569.44M |
$2.41M |
|
$321.48M |
|
$890.92M |
|
$272.82M |
|
$310.25M |
|
$375.60M |
|
$648.42M |
|
$242.49M |
|
$-11.66M |
|
$242.49M |
|
60.93M |
|
| Cash Flow Statement Financials | |
$-228.76M |
|
$-11.57M |
|
$270.08M |
|
$298.17M |
|
$326.64M |
|
$28.48M |
|
$36.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
0.56 |
|
1.28 |
|
81.98% |
|
-493.78% |
|
-493.78% |
|
-- |
|
-493.91% |
|
-494.21% |
|
$-229.43M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
1.13 |
|
1.20 |
|
74.93 |
|
-325.85% |
|
6776.64% |
|
-88.69% |
|
-142.95% |
|
$3.98 |
|
$-3.90 |
|
$-3.89 |
|